2006 -2022 Initiative Leader (pneumococcal, meningococcal and group B streptococcal vaccines) @
1995 -2005 Senior Director @ Corixa Corporation
1989 -1995 Staff Scientist @ Immunex
Mark Alderson Education
Seattle University
MBA (Finance, Management)
2002-2005
University of Melbourne
PhD (Immunology)
1985-1988
The University of Western Australia
BSc (Microbiology/Biochemistry)
1980-1983
Mark Alderson Skills
Vaccines
Infectious Diseases
Clinical Development
Technology Transfer
Biotechnology
Immunology
Biopharmaceuticals
Regulatory Submissions
Lifesciences
Cancer
Drug Discovery
GCP
Commercialization
CRO
Drug Development
Clinical Trials
FDA
Pharmaceutical Industry
Oncology
Biochemistry
Protein Chemistry
Molecular Biology
Cell
Life Sciences
Microsoft Office
Research
Chemistry
Mark Alderson Summary
Mark Alderson, based in Seattle, WA, US, is currently a Chief Scientific Officer at Maxvax Biotechnology. Mark Alderson brings experience from previous roles at PATH, Corixa Corporation and Immunex. Mark Alderson holds a 2002 - 2005 MBA in Finance, Management @ Seattle University. With a robust skill set that includes Vaccines, Infectious Diseases, Clinical Development, Technology Transfer, Biotechnology and more. Mark Alderson has 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.